Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The Walt Disney Co. (DIS) rose about 3% in the latest session, helped by trading volume that ran above recent averages, as market participants pointed to shifting earnings expectations.
THE APEX TIMES
THE APEX TIMES
The search giant is expanding the role of its Tensor Processing Units in building and serving artificial intelligence workloads, setting up a more direct contest with Nvidia’s dominant GPU ecosystem in the data center.
THE APEX TIMES
A new round of agreements reported by Yahoo Finance suggests Meta is scaling up the compute capacity needed for its AI systems, though the company’s disclosures do not spell out timelines or dollar amounts in the reporting.
THE APEX TIMES
Shares of Intel and other semiconductor names rose as investors reacted to comments attributed to Donald Trump, reviving appetite for the broader chip sector.
THE APEX TIMES
A fresh regulatory concern in Europe is focusing on how Tesla’s supervised self-driving system handles speed, highlighting the gap between product capability claims and regulator expectations.
THE APEX TIMES
In a new customer-facing post, Verizon frames its latest wireless approach as a break from industry norms, centered on loyalty incentives and a streamlined plan structure aimed at reducing the complexity many consumers associate with mobile service.
THE APEX TIMES
The operator says it is rolling out what it calls the first loyalty program in the industry that incorporates rebates for customers, as it positions new benefits around retention and customer value rather than traditional promotions.
THE APEX TIMES
The telecom operator says its new loyalty initiative for all customers includes cash back delivered through Verizon Dollars and features Verizon says will bring daily surprises.
THE APEX TIMES
UnitedHealth Group is taking an advisor role with Optura, a healthcare-focused artificial intelligence startup, according to a report by Yahoo Finance. The startup’s advisory group also includes former top executives from Humana and CVS Health.
